Research graph
References from Mining the nanotube-forming Bacillus amyloliquefaciens MR14M3 genome for determining anti- Candida auris and anti- Candida albicans potential by pathogenicity and comparative genomics analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Emerging status of multidrug-resistant bacteria and fungi in the arabian peninsula
10.3390/biology10111144 · 2021 · External reference
Candida auris infections in China
10.1080/21505594.2022.2054120 · 2022 · External reference
Candida auris: an overview of the emerging drug-resistant fungal infection
10.3947/ic.2022.0008 · 2022 · External reference
Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
10.1111/j.1348-0421.2008.00083.x · 2009 · External reference
Candida auris biofilm: a review on model to mechanism conservation
2023 · External reference
Novel intravenous immunoglobulin therapy for the prevention and treatment of Candida auris and candida albicans disseminated candidiasis
2023 · External reference
Update on the pathogenesis, virulence, and treatment of Candida auris
10.20411/pai.v7i2.535 · 2022 · External reference
Therapeutic intervention for various hospital setting strains of biofilm forming candida auris with multiple drug resistance mutations using nanomaterial Ag-Silicalite-1 Zeolite
10.3390/pharmaceutics14102251 · 2022 · External reference
Drug repurposing against Candida auris: a systematic review
10.1111/myc.13477 · 2022 · External reference
10.1016/j.micres.2020.126621
10.1016/j.micres.2020.126621 · External reference
10.1371/journal.ppat.1008921
10.1371/journal.ppat.1008921 · External reference
Candida auris: a mini review on epidemiology in health care facilities in asia
10.3390/jof8111126 · 2022 · External reference
In vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical isolates of Candida auris
10.1128/aac.00435-17 · 2017 · External reference
A second-generation fungerp analog, SCY-247, shows potent in vitro activity against candida auris and other clinically relevant fungal isolates
2021 · External reference
T-2307 causes collapse of mitochondrial membrane potential in yeast
10.1128/aac.05954-11 · 2012 · External reference
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against Candida auris
10.1128/aac.02198-19 · 2020 · External reference
In vitro and in vivo evaluation of the antifungal activity of APX001A/APX001 against Candida auris
10.1128/aac.02319-17 · 2018 · External reference
The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris
10.1128/aac.02233-18 · 2019 · External reference
In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates
10.1111/myc.13260 · 2021 · External reference
Antifungal activity of the phenolic compounds ellagic acid (EA) and caffeic acid phenethyl Ester (CAPE) against drug-resistant Candida auris
10.3390/jof7090763 · 2021 · External reference
In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris
10.1007/s00253-020-10829-z · 2020 · External reference
Activity of free and liposome-encapsulated essential oil from lavandula angustifolia against persister-derived biofilm of Candida auris
10.3390/antibiotics11010026 · 2021 · External reference
10.1126/science.abd6919
10.1126/science.abd6919 · External reference
Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle–mediated trafficking
10.1172/jci145123 · 2021 · External reference
Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris
10.1016/j.ijantimicag.2020.106049 · 2020 · External reference
Synthesis of silver nanoparticles using curcumin-cyclodextrins loaded into bacterial cellulose-based hydrogels for wound dressing applications
10.1021/acs.biomac.9b01724 · 2020 · External reference
Environmental surfaces in health care facilities are a potential source for transmission of candida auris and other Candida Species
10.1017/ice.2017.127 · 2017 · External reference
Different efficacies of common disinfection methods against candida auris and other candida species
10.1016/j.jiph.2020.01.008 · 2020 · External reference
Genomic analysis of limosilactobacillus fermentum ATCC 23271, a potential probiotic strain with anti-candida activity
10.3390/jof7100794 · 2021 · External reference
Isolation of vaginal lactobacilli and characterization of anti-candida activity
10.1371/journal.pone.0131220 · 2015 · External reference
Complete genome sequence and antimicrobial activity of Bacillus velezensis JT3-1, a microbial germicide isolated from yak feces
10.1007/s13205-020-02235-z · 2020 · External reference
Antifungal activity and biosynthetic potential of new streptomyces sp. MW-W600-10 strain isolated from coal mine water
10.3390/ijms22147441 · 2021 · External reference
Whole genome sequencing and metabolomic study of cave streptomyces isolates ICC1 and ICC4
10.3389/fmicb.2019.01020 · 2019 · External reference
The integration of genome mining, comparative genomics, and functional genetics for biosynthesis-related gene cluster identification
10.3389/fgene.2020.600116 · 2020 · External reference
Genome features and secondary metabolites biosynthetic potential of the class ktedonobacteria
10.3389/fmicb.2019.00893 · 2019 · External reference
Drug resistance-associated mutations in ERG11 of multidrug-resistant candida auris in a tertiary care hospital of eastern saudi arabia
10.3390/jof7010018 · 2020 · External reference
10.2144/000112517
10.2144/000112517 · External reference
Novel feather degrading keratinases from bacillus cereus group: biochemical, genetic and bioinformatics analysis
10.3390/microorganisms10010093 · 2022 · External reference
Predominance of non-Streptococcus mutans bacteria in dental biofilm and its relation to caries progression
10.1016/j.sjbs.2021.08.052 · 2021 · External reference
10.1093/molbev/msy096
10.1093/molbev/msy096 · External reference
10.1099/ijsem.0.001755
10.1099/ijsem.0.001755 · External reference
NanoForms: an integrated server for processing, analysis and assembly of raw sequencing data of microbial genomes, from Oxford Nanopore technology
10.7717/peerj.13056 · 2022 · External reference
NanoGalaxy: nanopore long-read sequencing data analysis in Galaxy
10.1093/gigascience/giaa105 · 2020 · External reference
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
10.1038/s41467-019-10210-3 · 2019 · External reference
10.1093/nar/gkw1017
10.1093/nar/gkw1017 · External reference
PATRIC as a unique resource for studying antimicrobial resistance
10.1093/bib/bbx083 · 2019 · External reference
10.1128/aac.02412-14
10.1128/aac.02412-14 · External reference
10.1371/journal.pone.0077302
10.1371/journal.pone.0077302 · External reference
10.1093/nar/gkab335
10.1093/nar/gkab335 · External reference
10.1016/j.jbc.2022.102480
10.1016/j.jbc.2022.102480 · External reference
In vitro and in vivo evaluation of the antifungal activity of APX001A/APX001 against Candida auris
10.1128/aac.02319-17 · 2018 · External reference
Antifungal activity of the phenolic compounds ellagic acid (EA) and Caffeic Acid Phenethyl Ester (CAPE) against drug-resistant Candida auris
10.3390/jof7090763 · 2021 · External reference
Isolation of candida auris in clinical specimens
10.1007/978-1-0716-2417-3_1 · 2022 · External reference
Anti-Candida and anti-quorum sensing activity of airborne microorganisms detected by a rapid method
10.1590/0037-8682-0152-2018 · 2019 · External reference
The antimicrobial potential of bacteria isolated from honey samples produced in the apiaries located in pomeranian voivodeship in Northern Poland
10.3390/ijerph15092002 · 2018 · External reference
Lactobacillus biofilms influence anti-candida activity
10.3389/fmicb.2021.750368 · 2021 · External reference
Anti-Candida activity of spent culture filtrate of Lactobacillus plantarum strain LR/14
10.1016/j.mycmed.2013.11.001 · 2014 · External reference
Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans
10.1016/j.jbiosc.2016.03.013 · 2016 · External reference
10.1007/s12602-010-9046-3 · 2010 · Admitted local publication
Anticandidal activity of Lactobacillus spp. in the presence of galactosyl polyols
10.1016/j.micres.2020.126540 · 2020 · External reference
Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans
10.1046/j.1365-2672.1999.00918.x · 1999 · External reference
Anticandidal activities by lactobacillus species: an update on mechanisms of action
10.3389/froh.2021.689382 · 2021 · External reference
Candida albicans morphologies revealed by scanning electron microscopy analysis
10.1590/s1517-83822013005000056 · 2013 · External reference
10.3390/microorganisms8091300
10.3390/microorganisms8091300 · External reference
Ultrastructure of Candida albicans pleomorphic forms: phase-contrast microscopy, scanning and transmission electron microscopy
10.33073/pjm-2012-016 · 2012 · External reference
The emerging pathogen candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation
10.1128/aac.02396-16 · 2017 · External reference
Lactobacilli with probiotic potential in the prairie vole (Microtus ochrogaster
10.1186/s13099-015-0082-0 · 2015 · External reference
Relationship of Bacillus amyloliquefaciens clades associated with strains DSM 7T and FZB42T: a proposal for Bacillus amyloliquefaciens subsp. amyloliquefaciens subsp. nov. and Bacillus amyloliquefaciens subsp. plantarum subsp. nov. based on complete genome sequence comparisons
10.1099/ijs.0.023267-0 · 2011 · External reference
10.1016/j.jbiotec.2011.01.006
10.1016/j.jbiotec.2011.01.006 · External reference
Biocontrol mechanism by root-associated Bacillus amyloliquefaciens FZB42 – a review
2015 · External reference
A review on the biotechnological applications of the operational group Bacillus amyloliquefaciens
10.3390/microorganisms9030614 · 2021 · External reference
Bacillus amyloliquefaciens as an excellent agent for biofertilizer and biocontrol in agriculture: An overview for its mechanisms
10.1016/j.micres.2022.127016 · 2022 · External reference
Biocontrol Ability of the Bacillus amyloliquefaciens Group, B. amyloliquefaciens, B. velezensis, B. nakamurai, and B. siamensis, for the Management of Fungal Postharvest Diseases: A Review
10.1021/acs.jafc.2c01745 · 2022 · External reference
Prebiotic, probiotic, antimicrobial, and functional food applications of bacillus amyloliquefaciens
10.1021/acs.jafc.0c06396 · 2020 · External reference
10.3390/microorganisms10051040
10.3390/microorganisms10051040 · External reference
10.1038/nbt.3423
10.1038/nbt.3423 · External reference
The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community
10.1186/s13059-016-1103-0 · 2016 · External reference
10.1038/s41587-021-01108-x
10.1038/s41587-021-01108-x · External reference
Perspectives and benefits of high-throughput long-read sequencing in microbial ecology
10.1128/aem.00626-21 · 2021 · External reference
Structural and functional characterization of gene clusters directing nonribosomal synthesis of bioactive cyclic lipopeptides in Bacillus amyloliquefaciens strain FZB42
10.1128/jb.186.4.1084-1096.2004 · 2004 · External reference
10.1002/anie.201208344
10.1002/anie.201208344 · External reference
Lipopeptides as main ingredients for inhibition of fungal phytopathogens by Bacillus subtilis/amyloliquefaciens
10.1111/1751-7915.12238 · 2015 · External reference
Responses of beneficial Bacillus amyloliquefaciens SQR9 to different soilborne fungal pathogens through the alteration of antifungal compounds production
2014 · External reference
